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We report the synthesis of the sensitive and specific fluorogenic self-immolative substrate 8b, 
which is hydrolzyed by β-alanyl aminopeptidase (BAP), resulting in a 1,6-elimination and the 
release of the highly fluorescent hydroxycoumarin 6b. This fluorophore 6b is retained within 
bacterial colonies, so has potential for the detection of P. aeruginosa (a BAP producer); it 
also has potential in liquid media due to the rapid and strong signal release from the substrate 
8b, and lack of self-quenching or photobleaching. 
Introduction 
The Gram negative aerobic bacterium 
Pseudomonas aeruginosa is the 6th most 
common causative pathogen in healthcare-
associated infections (HAI), being 
responsible for around 20% of hospital 
acquired disease.  In immunosuppressed 
patients, such as burns patients, and those 
with cancer or AIDS, as few as 10-100 P. 
aeruginosa cells can lead to gut 
colonization.1 P. aeruginosa is the major 
determinant of morbidity and mortality in 
cystic fibrosis patients, and 80% of adult 
patients harbour mucoid strains which even 
aggressive antibacterial therapy may be 
unable to eradicate.2 It has been reported that 
the nosocomial mortality associated with P. 
aeruginosa bloodstream infections is greater 
than 20%, and is highest among patients who 
have received inappropriate initial empirical 
antimicrobial treatment, thus rapid directed 
antibiotic therapy is imperative.3  
In addition to its simple nutritional 
requirements and ability to grow in the 
absence of oxygen and over a wide 
temperature range, P. aeruginosa has the 
largest and most complicated bacterial 
genome (6.3 M base pairs), which contains a 
large number of genes for the catabolism, 
transport, and efflux of many antibacterial 
drug classes, resulting in extensive 
antibacterial resistance.4 Early and rapid 
detection of P. aeruginosa is essential to 
prevent its transformation into the extremely 
hard to treat mucoid phenotype and to 
facilitate the maximum benefit from directed 
antibacterial therapy, involving combinations 
of an aminoglycoside with a β–lactam 
(penicillin or cephalosporin) or with a 
carbapenem and fluoroquinolone.  
For the identification of bacteria, 
chromogenic and fluorogenic enzyme 
substrates are widely used due to their 
excellent sensitivities and specificities, ease 
of use and interpretation, cost effectiveness, 
and lack of requirement for instrumentation. 
We have previously reported the use of a 
medium containing 7-N-β-alanyl-1-
pentylresorufamine (7-N-β-alanyl-1-PRF) 1 
for the detection of P. aeruginosa; the 
conversion of this substrate 1 to 1-PRF 2 is 
catalyzed by β-alanyl aminopeptidase (BAP), 
which is specific to this organism, Figure 1.5  
Due to its excellent specificity and 
sensitivity, this medium now forms the basis 
of a commercial diagnostic test for this 
pathogen.6 One drawback with chromogenic 
media in general is the time taken for the 
generation of the coloured signal (usually 24-
48 hours) and we sought to address this in the 
current work through the enhanced detection 
sensitivities of fluorogenic substrates, which 
should result in greatly reduced times to 
detection.  
Results and discussion  
As can be seen in Figure 1, BAP activity 
usually liberates β-alanine and an amine; we 
have synthesized two novel fluorogenic 
substrates 8a,b in which BAP activity would 
result in the release of a fluorescent phenol 
reporter, by linking β-alanine 4 to a 
hydroxycoumarin 6 via a para-
aminobenzylalcohol-based linker. One of the 
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advantages of these substrates is their 
straightforward synthesis, which involves the 
coupling of Boc-β-alanine 4 with para-
aminobenzylalcohol 3 to give alcohol 5, 
conversion of the primary alcohol to a better 
leaving group (OMs or Cl) and coupling to 
the phenoxide form of the 7-
hydroxycoumarin 6, and, finally, Boc 
deprotection of the β-ala-linker-
hydroxycoumarins 7 to give the 
trifluoroacetate salts 8, Figure 2. The specific 
hydrolysis of these substrates at the β-alanine 
amide bond is followed by a 1,6-elimination 
and the self-immolative7 loss of a p-
aminobenzylidene fragment, resulting in the 
release of the 7-hydroxycoumarin derivatives 
6, Figure 3. These coumarins have pKa 
values of 7.8 (6a)8 and 7.3 (6b),‡ so the latter 
will exist to a greater extent in the phenoxide 
form at neutral pH, and thus exhibit stronger 
fluorescence.9  It is this generation of a 
phenol 6 which results in the retention of the 
fluorescence within the bacterial colonies, 
Figure 4a. As can be seen from Figure 4 and 
Table 1, the only microorganisms which 
generate the characteristic fluorescence when 
grown on an agar medium containing 
substrate 8b are the known BAP producers, 
P. aeruginosa (spot 7), Burkholderia cepacia 
(spot 9) and Serratia marcescens (spot 5).  In 
contrast, the BAP-catalyzed hydrolysis of 7-
N-β-alanylamino-4-methylcoumarin 9 
generates 7-amino-4-methylcoumarin (7-
AMC) 10, which is not retained by bacterial 
colonies and spreads into the agar medium, 
thus complicating the detection of P. 
aeruginosa in the presence of other 
microorganisms.  
Having demonstrated the specificity of an 
agar medium containing substrate 8b for the 
detection of BAP producers, we next 
examined the behaviour of this substrate in 
liquid media in a microtiter plate 
arrangement. A range of E. coli (1), P. 
aeruginosa (7) and S. marcescens (4) strains 
were incubated with substrates 8a,b and 9.§ 
Within the microplate reader arrangement, 
the chosen cell lines were incubated at a final 
microorganism concentration of 0.25 
McFarland in Trypcase Soy Broth in the 
presence of the substrates at 50mg/L.  
To ensure satisfactory growth, the cell 
density within the wells was determined by 
measuring the absorption at 660 nm over 24 
hours; no growth inhibition was observed in 
the presence of any of the substrates (see 
ESI). After an initial lag phase of 10-20 
cycles (1 cycle = 15 mins), presumably 
caused by stress, all strains grew and 
multiplied, with no significant differences 
between the wells in the absence, or 
presence, of the substrates.  
The relative fluorescent signal intensity 
originating from each well was recorded 
every 15 minutes for 24 hours at two sets of 
excitation and emission wavelengths. 
Differences in the emission intensity were 
observed; β-Ala-7-AMC 9 gave more 
sensitive results at an excitation wavelength 
of 365 nm and an emission wavelength of 
440 nm, while substrate 8b exhibited greater 
sensitivity upon excitation at 375 nm and 
emission at 445 nm, for fluorophore 6a the 
intensities were essentially identical at both 
sets of wavelengths. No fluorescence was 
observed in any of the control wells in the 
absence of strains and / or in the absence of 
any substrates. All β-alanyl aminopeptidase 
producers (apart from 2 S. marcescens 
strains; ATCC 264 and ATCC 43861) 
displayed fluorescence during the course of 
these studies, while the control organism, E. 
coli, generated no fluorescence, as expected. 
Substrate 8a was hydrolyzed by all BAP 
producers, but the fluorescence intensities 
were lower than for both substrates 8b and 9 
over the entire kinetic runs (presumably as a 
result of its higher pKa and so lower 
ionization in the test wells). The fluorescence 
measurements at 365 nm (ex) / 440 nm (em) 
showed β-Ala-7-AMC 9 and substrate 8b to 
be equally reliable in the detection of BAP 
activity (after 24 hours), with the emission 
intensities reaching the same levels by the 
end of the kinetics.  On the other hand, unlike 
that from the hydrolysis of substrate 8b, the 
fluorescence signal from the hydrolysis of β-
Ala-7-AMC 9 declined over the time period 
of the kinetics (presumably due to self-
quenching /photobleaching), and this could 
lead to false negative results. 
However, when the emission was detected at 
445 nm after excitation at 375 nm, substrate 
8b resulted in significantly greater 
fluorescence intensities than those from β-
Ala-7-AMC 9, with the additional benefit of 
a more persistent signal (no self-quenching or 
photobleaching), Figure 6. Even the time 
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taken to detection of the fluorescence 
generated by these substrates was 
comparable; in some cases the signal was 
slightly slower to develop for substrate 8b, 
but only by a maximum of 10 cycles (2.5 
hours) which, in a clinical setting, would not 
result in any significant deficiencies. 
Conclusions 
In summary, the fluorogenic substrate 8b, 
which consists of β-alanine attached via a 
self-immolative p-aminobenzylalcohol 
unit to 2-carbethoxy-7-hydroxycoumarin 
6b, is a specific and sensitive probe for 
the detection of BAP producers, in 
particular the opportunistic Gram 
negative ESKAPE pathogen P. 
aeruginosa.  The synthetic route to this 
substrate is simpler and more efficient 
than that to the chromogenic substrate 1 
and a medium containing this fluorogenic 
substrate has the potential for more rapid 
detection of P. aeruginosa than 
chromogenic media.  This substrate 8b 
also has advantages over another 
fluorogenic substrate, 7-N-β-alanylamino-
4-methylcoumarin 9, as it is retained by 
bacterial colonies in solid agar 
applications, and results in similar times 
to detection, stronger fluorescence 
intensities, and no decrease in signal over 
time in liquid media. 
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Figures and captions 
 
(a) (b) 
 
Figure 1.  Diagram illustrating the principle behind the chromogenic detection of Pseudomonas 
aeruginosa colonies and the origin of the purple colour (a), using chromID™ P. 
aeruginosa (b).  
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Figure 2.  Synthesis of self-immolative BAP substrates 8. Reagents and conditions: i) 
Boc-β-ala 4, DIPEA, HOBt, Et3N, THF, 0 °C, N2; ii) DIPEA, MsCl, DCM, 0 
°C, N2; iii) 6, K2CO3, DCM; iv) THF, DCM. 
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Figure 3. The principle behind the chromogenic detection of Pseudomonas aeruginosa 
colonies using the self-immolative β-alanyl aminopeptidase substrate 8 or 7-N-
β-alanylamino-4-methylcoumarin 9 to generate the strongly fluorescent 
hydroxycoumarins 6 or 7-amino-4-methylcoumarin (7-AMC) 10. 
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(a) (b) 
Figure 4. Representative Gram positive, Gram negative, and yeast microorganisms 
grown on an agar medium containing substrate 8b; fluorescence corresponds 
only to the known BAP producers, Pseudomonas aeruginosa (spot 7), 
Burkholderia cepacia (spot 9) and Serratia marcescens (spot 5). 
 
Table 1. List of microorganisms inoculated onto incubation plates and corresponding 
spots (100,000 CFU/spot) in Figure 4. 
Spot Organism Spot   Organism 
1 Escherichia coli 11 Steptococcus pyogenes 
2 Klebsiella pneumoniae 12 Staphylococcus aureus (MRSA) 
3 Providencia rettgeri 13 Staphylococcus aureus 
4 Enterobacter cloacae 14 Staphylococcus epidermidis 
5 Serratia marcescens 15 Listeria monocytogenes 
6 Salmonella typhimurium 16 Enterococcus faecium 
7 Pseudomonas aeruginosa 17 Enterococcus faecalis 
8 Yersinia enterocolitica 18 Bacillus subtilis 
9 Burkholderia cepacia 19 Candida albicans 
10 Acinetobacter baumannii 20 Candida glabrata 
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(a) (b) 
Figure 5. Fluorescence generated on media containing substrate 8b by BAP producers: 
(a) Burkholderia cepacia and Serratia marcescens; (b) Pseudomonas 
aeruginosa. 
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Figure 6. Kinetic data for the release of fluorophores 8b (•) and 9 () in liquid media in 
(a) P. aeruginosa ATCC 27853; (b) P. aeruginosa API 14 02 103 
(bioMérieux strains collection). Fluorescence was recorded at 365 nm (ex) / 
440 nm (em) (dotted line) and 375 nm (ex) / 445 nm (em) (solid line). 
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1. Chemistry 
1.1 General 
All reagents and solvents were purchased from Sigma-Aldrich, Alfa Aesar, and ChemSupply, 
and used without any further purification or treatment. Compound 6b was prepared as 
previously reported.1 Thin layer chromatography was performed on Grace Reveleris® Silica 
Aluminum-backed TLC Plates (UV254). 1H and 13C NMR spectra were acquired on a Varian 
400MR at 400 MHz and 100 MHz, respectively. Coupling constants (J) are in Hertz (Hz), 
chemical shifts (δ) are expressed in parts per million (ppm) and reported relative to residual 
solvent peaks. Low resolution mass spectra were obtained on TSQ Quantum Access Max 
(triple quadrupole) LCMS/MS in positive ion mode. High resolution mass spectra were 
obtained on a Bruker 7T Fourier Transform Ion Cyclotron Resonance Mass Spectrometer 
(FTICR), also in positive ion mode. Infrared spectra were recorded on Shimadzu FTIR-8400S 
and Shimadzu IRTracer-100 spectrometers. Elemental analyses were performed by the 
Campbell Microanalytical Laboratory at the University of Otago, NZ. 
1.2 4-(Boc-β-Alanylamido)benzyl alcohol 5 
 
 
To a solution of 4-aminobenzyl alcohol 3 (1 g, 8 mmol) in anhydrous THF (150 mL), 
hydroxybenzotriazole hydrate (HOBt, 1.08 g, 8 mmol), Boc-β-alanine-OH 4 (1.51 g, 8 
mmol), and EDAC hydrochloride (1.9 g, 10 mmol) were added sequentially, at 0 °C. 
Triethylamine (2.2 mL, 16 mmol) was then added and the resulting solution was stirred at 
room temperature overnight. Further portions of triethylamine (2.2 mL) were added until 
completion of the reaction. The solvent was then removed, the residue was taken up in ethyl 
acetate (150 mL) and washed with water (150 mL), 1M HCl (50 mL), and then saturated aq. 
NaHCO3 (50 mL). The organic layer was dried over Na2SO4 and concentrated under vacuum. 
Column chromatography, eluting with hexane : ethyl acetate (1:2), gave the desired product 5 
                                                          
1
 C. Ritter, N. Nett, C.G. Acevedo-Rocha, R. Lonsdale, K. Kräling, F. Dempwolff, S. Hoebenreich, P.L. Graumann, 
M.T. Reetz, E. Meggers; Angew.Chem. Int. Ed., 2015, 54,13440–13443. 
4 
as an off-white solid (1.45 g, 61%); mp 110-118 oC; (found C, 61.50; H, 7.68; N, 9.62. 
C15H22N2O4 requires C, 61.21; H, 7.53; N, 9.52 %); νmax/cm-1 3354 (NH), 3324 (NH), 1689 
(amide I), 1528 (amide II); 1H NMR (400 MHz, DMSO-d6) δH 1.37 (9H, s, CMe3), 2.45 (2H, 
t, J = 7.2 Hz, CH2-2'), 3.20 (2H, q, J = 7.2 Hz, CH2-3'), 4.42 (2H, d, J = 5.2 Hz, CH2OH), 
5.08 (1H, t, J= 5.6 Hz, NH carbamate), 6.86 (1H, t, J = 5.2 Hz, OH), 7.22 (2H, d, J = 8.4 Hz, 
H-2,6), 7.53 (2H, d, J = 8.4 Hz, H-3,5), 9.88 (1H, s, NH amide); 13C NMR (100 MHz, 
DMSO-d6) δC 28.7 (3 × CH3, CMe3), 36.9 (CH2), 37.1 (CH2), 63.0 (CH2OH), 78.0 (quat., 
CMe3), 119.2 (2 × ArCH), 127.3 (2 × ArCH), 137.6 (quat.), 138.2 (quat.), 156.0 (quat., 
C=O), 169.6 (quat., C=O); MS (ESI) m/z 317 (MNa+). 
1.3 7-{4-(Boc-β-Alanylamido)}benzyloxy-4-methylcoumarin 7a 
 
To a solution of N-(N’-tert-Butoxycarbonyl-β-alanyl)-4-aminobenzyl alcohol 5 (1 g, 3.4 
mmol) in dry DCM (40 mL) under an inert atmosphere at -10 °C, DIPEA (0.52 g, 4.0 mmol) 
was added, followed by the dropwise addition of methanesulfonyl chloride (0.423 g, 3.7 
mmol). The resulting reaction mixture was stirred for 3 hours at 0 °C. After completion, the 
reaction was quenched by pouring into a mixture of ice and concn. HCl (100 mL) then the 
separated organic layer was dried over Na2SO4 and concentrated in vacuo to give an off-
white oily solid, which was used without further purification in the next step. To a stirred 
solution of 4-methylumbelliferone 6a (0.63 g, 3.6 mmol) and K2CO3 (1.15 g, 7 mmol) in 
dichloromethane, a solution of the mesylate (3.4 mmol) was added dropwise. The reaction 
mixture was stirred at room temperature overnight. After completion of the reaction, the 
organic layer was washed with water (5 × 25 mL), and brine (30 mL). The organic residues 
were purified by column chromatography on silica, eluting with hexane: ethyl acetate (1:2), 
to give 7-{4-(Boc-β-alanylamido)}benzyloxy-4-methylcoumarin 7a as a white solid (0.66 g, 
43%); mp 204.9-207.1 oC; (found C, 66.45; H, 6.37; N, 6.19. C25H28N2O6 requires C, 66.36; 
H, 6.24; N, 6.19 %); (found MNa+, 475.1842. Calc. for C25H28N2O6Na: MNa, 475.1839); 
νmax/cm-1 2960, 2927, 2860 (NH), 1737 (C=O), 1670 (C=O), 1516 (NH), 1224 (C-O), 1149 
(C-O); 1H NMR (400 MHz, DMSO-d6) δH 1.37 (9H, s, CMe3), 2.39 (3H, d, J = 1.2 Hz, CH3), 
2.47 (2H, t, J = 7.2 Hz, CH2-2'), 3.21 (CH2, q, J= 7.2 Hz, CH2-3'), 5.15 (2H, s, OCH2), 6.20 
(1H, d, J = 1.2 Hz, H-3), 6.84 (1H, br, NH, carbamate), 7.01 (1H, dd, J = 8.8 and 2.8 Hz, H-
5 
6), 7.05 (1H, d, J = 2.8 Hz, H-8), 7.39 (2H, d, J= 8.8 Hz, 2 × ArH), 7.61 (2H, d, J= 8.8 Hz, 2 
× ArH), 7.68 (1H, d, J = 8.8 Hz, H-5), 9.97 (1H, s, NH, amide); 13C NMR (100 MHz, 
DMSO-d6) δC 18.5 (CH3), 28.7 (CH3, CMe3), 36.9 (CH2-3'), 37.2 (CH2-2'), 70.1 (CH2, 
OCH2), 78.1 (quat., CMe3), 102.1 (CH, C-8), 111.6 (CH, C-3), 113.2 (CH, C-6), 113.7 (quat., 
C-4), 119.5 (2 × CH, C-3',5'), 126.9 (CH, C-5), 129.0 (2 × CH, C-2',6'), 131.1 (quat., C-4'), 
139.5 (quat., C-1'), 153.8 (quat., C-4a), 155.1 (quat., C-8a), 155.9 (quat., C=O, carbamate), 
160.55 (quat., C-2), 161.8 (quat., C-7), 169.9 (quat., C=O, amide); MS (ESI) m/z 475 
(MNa)+, 353 (M-tBoc)+. 
1.4 7-{4-(Boc-β-Alanylamido)}benzyloxy-3-ethoxycarbonylcoumarin 7b 
 
N-(N'-tert-Butoxycarbonyl-β-alanyl)-4-aminobenzyl alcohol 5 (0.71 g, 2.4 mmol) was 
dissolved in dry dichloromethane (20 mL) under an inert atmosphere and cooled in an 
acetone-ice bath. DIPEA (0.37 g, 2.88 mmol) was added, followed by the dropwise addition 
of methanesulfonyl chloride (0.33 g, 2.88 mmol) and the reaction mixture was stirred for 2 
hours at 0 °C, then poured onto an ice-concn. HCl mixture (50 mL). After separation, the 
organic layer was added to a stirred solution of 6b (0.4 g, 1.71 mmol) and K2CO3 (1.41 g, 
8.55 mmol) in dichloromethane. The reaction mixture was stirred at room temperature 
overnight and after completion of the reaction, the organic layer was washed with water (3 × 
15 mL). The resulting organic layer was dried over Na2SO4 and evaporated under vacuum. 
The solid residue obtained was recrystallised from ethyl acetate to give 7-{4-(Boc-β-
alanylamido)}benzyloxy-3-ethoxycarbonylcoumarin 7b as a pale yellow solid (0.42 g, 48 %); 
mp 196.8-199.6 oC; (found C, 63.52; H, 5.92; N, 5.49. C27H30N2O8 requires C, 63.26; H, 
5.90; N, 5.41 %); (found: MNa+, 533.1896. Calc. for C27H30N2O8Na: MNa, 533.1894); 
νmax/cm-1 2922 (NH), 2850 (NH), 1743 (C=O), 1683 (C=O), 1602 (NH), 1521 (NH), 1373, 
1217 (C-O), 1176 (C-O); 1H NMR (400 MHz, DMSO-d6) δH 1.30 (3H, t, J = 7.2 Hz, 
CH3CH2), 2.47 (2H, t, J = 6.8 Hz, CH2-2'), 3.21 (2H, q, J = 7.2 Hz, CH2-3'), 4.27 (2H, q, J = 
7.2 Hz, CH2CH3), 5.18 (2H, s, OCH2), 6.84 (1H, br, NH, carbamate), 7.06 (1H, dd, J = 8.8 
and 2.8 Hz, H-6), 7.10 (1H, d, J = 2.8 Hz, H-8), 7.40 (2H, d, J = 8.8 Hz, H-3’,5’), 7.62 (2H, 
d, J = 8.8 Hz, H-2’,6’), 7.84 (1H, d, J = 8.8 Hz, H-5), 8.71 (1H, s, H-4), 10.00 (1H, s, NH, 
6 
amide); 13C NMR (100 MHz, DMSO-d6) δC 14.6 (CH3), 28.7 (CH3, CMe3), 36.9 (CH2-3'), 
37.2 (CH2-2'), 61.4 (CH2, OCH2CH3), 70.5 (CH2, OCH2), 78.1 (quat., CMe3), 101.6 (CH, C-
8), 111.9 (quat.), 113.9 (quat., C-8a), 114.3 (CH, C-6), 119.5 (2 × CH, C-3',5'), 129.2 (2 × 
CH, C-2',6'), 130.8 (quat., C-1'), 132.1 (CH, C-5), 139.7 (quat., C-4'), 149.6 (CH, C-4), 155.9 
(quat., C=O, carbamate), 156.7 (quat., C-3), 157.3 (quat., C-4a), 163.3 (quat., C=O, CO2Et), 
164.2 (quat., C-7), 169.9 (quat., C=O, amide); MS (ESI) m/z 533.5 (MNa)+, 511 (MH)+.  
1.5 7-{4-(β-Alanylamido)}benzyloxy-4-methylcoumarin trifluoroacetate 8a 
 
To a solution of 7-{4-(Boc-β-alanylamido)}benzyloxy-4-methylcoumarin 7a (0.2 g, 0.46 
mmol) in methanol, trifluoroacetic acid was added in two portions (2× 5 mL). Upon 
completion of the reaction the excess TFA was removed via repeated co-evaporation with 
methanol (5 × 10 mL). The resulting residue was triturated with cold diethyl ether to give 7-
{4-(β-alanylamido)}benzyloxy-4-methylcoumarin trifluoroacetate 8a as a white crystalline 
solid (0.123 g, 56%); mp 200.0-202.8 oC;  (found C, 55.88; H, 4.54; N, 5.90. 
C22H21F3N2O6•0.5H2O requires C, 55.58; H, 4.66; N, 5.89 %); (found: MH+, 353.1500. Calc. 
for C20H21N2O4: MH, 353.1496); νmax/cm-1 3055-2968 (+NH3), 1695 (C=O), 1662 (C=O), 
1606 (NH), 1516 (NH), 1199 (C-O), 1188 (C-O); 1H NMR (400 MHz, DMSO-d6) δH 2.40 
(3H, s, CH3), 2.70 (2H, t, J = 6.4 Hz, CH2-2'), 3.09 (2H, t, J= 6.4 Hz, CH2-3'), 5.17 (2H, s, 
OCH2), 6.22 (1H, s, H-3), 7.02 (1H, d, J = 8.8 Hz, H-6), 7.06 (1H, d, J = 2.4 Hz, H-8), 7.42 
(2H, d, J = 8.4 Hz, H-3',5'), 7.62 (2H, d, J = 8.4 Hz, H-2',6'), 7.67 (3H, br, NH3), 7.69 (1H, d, 
J = 8.8 Hz, H-5), 10.20 (1H, s, NH); 13C NMR (100 MHz, DMSO-d6) δC 18.6 (CH3), 33.7 
(CH2), 35.4 (CH2), 70.0 (OCH2), 102.1 (CH, C-8), 111.7 (CH, C-3), 113.2 (CH, C-6), 113.7 
(quat., C-4), 119.6 (2 × CH, C-3',5'), 126.9 (CH, C-5), 129.1 (2 × CH, C-2',6'), 131.5 (quat., 
C-4'), 139.2 (quat., C-1'), 153.9 (quat., C-4a), 155.1 (quat., C-8a), 160.6 (quat., C-2), 161.8 
(quat., C-7), 168.9 (quat., C=O, amide); MS (ESI) m/z 353 (MH)+.  
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1.6 7-{4-(β-Alanylamido)}benzyloxy-3-ethoxycarbonylcoumarin trifluoroacetate 8b 
 
To a solution of 7b (100 mg, 0.196 mmol) in DCM (10 mL) trifluoroacetic acid (2 × 4 mL) 
was added. Upon completion of the reaction the excess the volatiles were removed via 
repeated co-evaporation with methanol (5 × 10 mL). The resulting residue triturated with cold 
diethyl ether to give 7-[4-(β-alanylamido)]benzyloxy-3-ethoxycarbonylcoumarin 
trifluoroacetate 8b as a white crystalline solid (0.102 g, 99 %); mp 196.4-198.3 oC; (found C, 
52.81; H, 4.20; N, 5.20. C24H23F3N2O8•H2O requires C, 53.14; H, 4.65; N, 5.16 %); (found: 
MH+, 411.1554. Calc. for C22H23N2O6: MH, 411.1551); νmax/cm-1 3122-2983 (+NH3), 1749 
(C=O), 1683 (C=O), 1670 (C=O), 1602 (NH), 1541 (NH), 1508, 1197 (C-O), 1182 (C-O); 1H 
NMR (400 MHz, DMSO-d6) δH 1.29 (3H, t, J = 7.2 Hz, CH3), 2.70 (2H, t, J= 6.8 Hz, CH2-
2'), 3.09 (2H, t, J = 6.8 Hz, CH2-3'), 4.26 (2H, q, J = 7.2 Hz, OCH2CH3), 5.19 (2H, s, OCH2), 
7.05 (1H, dd, J = 8.8 and 2.4 Hz, H-6), 7.10 (1H, d, J = 2.4 Hz, H-8), 7.42 (2H, d, J = 8.4 Hz, 
H-3',5'), 7.62 (2H, d, J = 8.4 Hz, H-2',6'), 7.79 (3H, br, NH3), 7.84 (1H, d, J = 8.8 Hz, H-5), 
8.72 (1H, s, H-4), 10.22 (1H, s, NH); 13C NMR (100 MHz, DMSO-d6) δC 14.6 (CH3), 33.7 
(CH2-2'), 35.4 (CH2-3'), 61.4 (CH2, OCH2CH3), 70.4 (CH2, OCH2), 101.6 (CH, C-8), 112.0 
(quat.), 113.9 (quat., C-8a), 114.3 (CH, C-6), 119.6 (2 × CH, C-3',5'), 129.3 (2 × CH, C-2',6'), 
131.1 (quat., C-1'), 132.1 (CH, C-5), 139.3 (quat., C-4’), 149.6 (CH, C-4), 156.7 (quat., C-3), 
157.3 (quat., C-4a), 163.3 (quat., C=O, COOEt), 164.2 (quat., C-7), 168.9 (quat., C=O, 
amide); MS (ESI) m/z 411 (MH)+. 
2. Microbiological testing 
2.1 Solid media 
Preparation of culture media containing substrates 8a and 8b 
Columbia agar was prepared as follows; 41 g of Columbia agar (Oxoid Basingstoke, UK) 
was added to deionised water and the volume was made up to 1 L. The medium was sterilised 
by autoclaving at 116 °C for 20 minutes and left to cool at 50 °C. 2 mg of each substrate 8a,b 
to be tested was initially dissolved in 100 µL of N-methylpyrrolidone and this was added to 
Columbia agar (made up to 20 mL), then poured into sterile Petri dishes to give a final 
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concentration of 100 mg/L for the substrates. Columbia agar incorporating an equivalent 
concentration of N-methylpyrrolidone was used as a growth control.  
Microbial suspension preparation 
Microbial reference strains were obtained from either the National Collection of Type 
Cultures (NCTC) or the National Collection of Pathogenic Fungi (NCPF) which are both 
located at the Central Public Health England Laboratory, Colindale, UK or the American 
Type Culture Collection (ATCC), Manassas, USA. The 20 test microorganisms were 
maintained on Columbia agar. 
Multipoint inoculation 
Colonies of each microbial strain were harvested using a loop from overnight cultures on 
Columbia agar. These were suspended in sterile deionised water to a suspension equivalent to 
0.5 McFarland units using a densitometer. 100 µL of this suspension was pipetted into the 
corresponding wells of a multipoint inoculation device. Each set of plates received 1 µL of 
bacterial suspension, giving 1.5 × 105 organisms per spot on each inoculation. Twenty strains 
were inoculated per plate and the plates were incubated for 18 hours in air at 37 °C. 
Activity determination 
After incubation, the activity of the microorganisms with the test substrates was determined 
by observing the plates under UV irradiation at 365 nm and comparing with the substrate-free 
control.  
2.2 Liquid media 
For the evaluation of substrates 8a,b and 9 in liquid media, 9 was purchased from Glycosynth 
(UK), N-methyl-2-pyrrolidinone (NMP) was purchased from ACROS ORGANICS. Trypcase 
Soy Broth (TSB BIOMERIEUX ref. 42 100) and Suspension Medium BIOMERIEUX (ref. 
70 640) were used. Microplate reader TECAN Infinite M-200 was used to record 
fluorescence (365/440 nm and 375/445 nm settings) and absorption (at 660 nm for organism 
density) during a 24 hour period of incubation of the 12 assessed strains on GREINER 96 
well plate (ref. 655 090) sealed with transparent GREINER viewseal (ref. 676 070). 
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Table S1. List of microorganisms inoculated onto 96-well plate for the evaluation of 8a,b 
and 9 
Species bioMérieux strains 
collection number 
ATCC / NCTC 
reference 
number 
E. coli API 00 08 013  
P. aeruginosa API 77 05 034 NCTC 10662 
S. marcescens API 04 04 009  
S. marcescens API 75 08 042 ATCC 264 
S. marcescens API 95 05 151 ATCC 43861 
P. aeruginosa API 10 11 314  
P. aeruginosa API 14 02 224 ATCC 27853 
P. aeruginosa API 10 06 028 ATCC 10145 
S. marcescens API 92 11 027  
P. aeruginosa API 08 04 064  
P. aeruginosa API 14 02 100  
P. aeruginosa API 14 02 103  
*:API xx xx xxx = bioMérieux strains collection number 
Method 
For 8a,b and 9, a 10 µL solution of substrate (at 50g/L in N-methylpirrolidone) was 
suspended in 5 mL of TSB (final concentration 100 mg/L). Every well was filled with 100 µL 
of specified solution of substrate and 100 µL of bacterial suspension at 0.5 McFarland for a 
final concentration of 0.25 McFarland (about 7.5 × 107 bacteria/mL). For control, in the 
absence of enzyme substrates the wells were filled with 100 µL TSB and 100 µL of bacterial 
suspension at 0.5 McFarland. For negative control, the wells were filled with 100 µL TSB 
with or in the absence or presence of any of the substrates and 100 µL Suspension Medium.  
The absorption (at 660 nm for microbial growth) and relative fluorescent intensities at the 
respective settings of λex= 365 nm / λem= 440 nm and λex= 375 nm / λem= 445 nm) for 
enzymatic activity were recorded over a period of 24 hours in 96 × 15 minute cycles. 
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Figure S1. Readings from wells in the absence of microorganisms containing no substrate 
(blue line), substrate 8a (grey line), substrate 8b (yellow line) or substrate 9 
(orange line), respectively; a) absorbance at 660 nm; b) fluorescent signal 
intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S2. Readings from wells containing E. coli (API 00 08 013) in the presence of no 
substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S3. Readings from wells containing P. aeruginosa NCTC 10662 in the presence of no 
substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S4. Readings from wells containing S. marcescens API 04 4 009 in the presence of no 
substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S5. Readings from wells containing S. marcescens ATCC 264 in the presence of no 
substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S6. Readings from wells containing S. marcescens ATCC 43861 in the presence of no 
substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S7. Readings from wells containing P. aeruginosa API 10 11 314 in the presence of 
no substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S8. Readings from wells containing P. aeruginosa ATCC 27853 in the presence of no 
substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S9. Readings from wells containing P. aeruginosa ATCC 10145 in the presence of no 
substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S10. Readings from wells containing S. marcescens API 92 11 027 in the presence of 
no substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S11. Readings from wells containing P. aeruginosa API 08 04 064 in the presence of 
no substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S12. Readings from wells containing P. aeruginosa API 14 02 100 in the presence of 
no substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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Figure S13. Readings from wells containing P. aeruginosa API 14 02 103 in the presence of 
no substrate (blue line), substrate 8a (grey line), substrate 8b (yellow line) or 
substrate 9 (orange line), respectively; a) absorbance at 660 nm; b) fluorescent 
signal intensities at 365 / 440 nm; c) fluorescent intensities at 375 / 445 nm. 
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3. NMR Spectra 
3.1 4-(Boc-β-Alanylamido)benzyl alcohol 5 1H NMR
 
24 
3.2 4-(Boc-β-Alanylamido)benzyl alcohol 5 13C NMR 
 
 
25 
3.3 7-{4-(Boc-β-Alanylamido)}benzyloxy-4-methylcoumarin 7a 1H NMR
26 
3.4 7-{4-(Boc-β-Alanylamido)}benzyloxy-4-methylcoumarin 7a 13C NMR 
 
27 
3.5 7-{4-(Boc-β-Alanylamido)}benzyloxy-3-ethoxycarbonylcoumarin 7b 1H NMR
28 
3.6 7-{4-(Boc-β-Alanylamido)}benzyloxy-3-ethoxycarbonylcoumarin 7b 13C NMR
 
29 
3.7 7-{4-(β-Alanylamido)}benzyloxy-4-methylcoumarin trifluoroacetate 8a 1H NMR
30 
3.8 7-{4-(β-Alanylamido)}benzyloxy-4-methylcoumarin trifluoroacetate 8a 13C NMR
 
31 
3.9 7-{4-(β-Alanylamido)}benzyloxy-3-ethoxycarbonylcoumarin trifluoroacetate 8b 
1H NMR
 
32 
3.10 7-{4-(β-Alanylamido)}benzyloxy-3-ethoxycarbonylcoumarin trifluoroacetate 8b 
13C NMR
 
